Jacobs Levy Equity Management
JNP

Jacobs Levy Equity Management’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Jacobs Levy Equity Management’s Portfolio JNP Stock Details JNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-29,701
Closed -$258K – 1138
2018
Q2 		$258K Sell
29,701
-3,800
-11% -$34.2K ﹤0.01% 918
2018
Q1 		$340K Sell
33,501
-5,800
-15% -$48.7K 0.01% 844
2017
Q4 		$191K Buy
39,301
+1,000
+3% +$4.86K ﹤0.01% 914
2017
Q3 		$174K Sell
38,301
-600
-2% -$2.82K ﹤0.01% 885
2017
Q2 		$196K Buy
38,901
+15,411
+66% +$68.9K ﹤0.01% 847
2017
Q1 		$112K Sell
23,490
-900
-4% -$4.55K ﹤0.01% 855
2016
Q4 		$137K Sell
24,390
-200
-0.8% -$1.1K ﹤0.01% 868
2016
Q3 		$136K Sell
24,590
-400
-2% -$2.65K ﹤0.01% 946
2016
Q2 		$175K Buy
+24,990
New +$176K ﹤0.01% 1032
2015
Q1 		– Sell
-51,229
Closed -$287K – 933
2014
Q4 		$287K Buy
+51,229
New +$298K ﹤0.01% 696

Jacobs Levy Equity Management's JNP Position: Q3 2018 in Review

Jacobs Levy Equity Management sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 29,701 shares — an estimated $258K sold.

Jacobs Levy Equity Management first reported a position in JNP in Q4 2014 and held it in 10 quarters. The position peaked at $340K in Q1 2018. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.

  • Jacobs Levy Equity Management reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 29,701 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $258K.
  • Jacobs Levy Equity Management first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q4 2014 and held it in 10 quarters.
  • Jacobs Levy Equity Management's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $340K in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2018, filed 14 Nov 2018.